[1] [1] MURRAY P J, ALLEN J E, BISWAS S K, et al. Macrophage activation and polarization:nomenclature and experimental guidelines[J]. Immunity, 2014, 41(1): 14-20.

[4] [4] CARTY F, MAHON B P, ENGLISH K. The influence of macrophages on mesenchymal stromal cell therapy:passive or aggressive agents?[J]. Clinical & Experimental Immunology, 2017, 188(1): 1-11.

[5] [5] CHO D I, KIM M R, JEONG H Y, et al. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages[J]. Experimental & Molecular Medicine, 2014, 46(1): e70-79.

[6] [6] DOMINICI M, LE BLANC K, MUELLER I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement[J]. Cytotherapy, 2006, 8(4): 315-317.

[7] [7] PITTENGER M F, MACKAY A M, BECK S C, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411): 143-147.

[8] [8] GRIFFIN M D, ELLIMAN S J, CAHILL E, et al. Concise review:adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?[J]. Stem Cells, 2013, 31(10): 2033-2041.

[9] [9] LE BLANC K, DAVIES L C. MSCs-cells with many sides[J]. Cytotherapy, 2018, 20(3): 273-278.

[10] [10] SHI Y, WANG Y, LI Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases[J]. Nature Reviews Nephrology, 2018, 14(8): 493-507.

[11] [11] WEISS A R R, DAHLKE M H. Immunomodulation by mesenchymal stem cells (MSCs):mechanisms of action of living, apoptotic, and dead MSCs[J]. Frontiers in Immunology, 2019, 10(1191): 1-10.

[12] [12] ZHU H, GUO Z K, JIANG X X, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone[J]. Nature Protocols, 2010, 5(3): 550-560.

[13] [13] GORDON S, MARTINEZ F O. Alternative activation of macrophages:mechanism and functions[J]. Immunity, 2010, 32(5): 593-604.

[14] [14] GORDON S, TAYLOR P R. Monocyte and macrophage heterogeneity[J]. Nature Reviews Immunology, 2005, 5(12): 953-964.

[15] [15] CHAZAUD B. Macrophages:supportive cells for tissue repair and regeneration[J]. Immunobiology, 2014, 219(3): 172-178.

[16] [16] WANG Q, DING G, XU X. Immunomodulatory functions of mesenchymal stem cells and possible mechanisms[J]. Histology and Histopathology, 2016, 31(9): 949-959.

[17] [17] TURINETTO V, VITALE E, GIACHINO C. Senescence in Human mesenchymal stem cells:functional changes and implications in stem cell-based therapy[J]. International Journal of Molecular Sciences, 2016, 17(7): 1164-1182.

[18] [18] STENDERUP K, JUSTESEN J, CLAUSEN C, et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells[J]. Bone, 2003, 33(6): 919-926.

[19] [19] WAGNER W, BORK S, HORN P, et al. Aging and replicative senescence have related effects on human stem and progenitor cells[J]. PloS One, 2009, 4(6): e5846-5859.

[20] [20] GALDERISI U, HELMBOLD H, SQUILLARO T, et al. In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes[J]. Stem Cells and Development, 2009, 18(7): 1033-1042.

[21] [21] MANTOVANI A, BISWAS S K, GALDIERO M R, et al. Macrophage plasticity and polarization in tissue repair and remodelling[J]. The Journal of Pathology, 2013, 229(2): 176-185.

[22] [22] MARRAZZO P, CRUPI A N, ALVIANO F, et al. Exploring the roles of MSCs in infections:focus on bacterial diseases[J]. Journal of Molecular Medicine, 2019, 97(4): 437-450.

[23] [23] GEISSMANN F, MANZ M G, JUNG S, et al. Development of monocytes, macrophages, and dendritic cells[J]. Science, 2010, 327(5966): 656-661.

[24] [24] BARRETT J P, HENRY R J, VILLAPOL S, et al. NOX2 deficiency alters macrophage phenotype through an IL-10/STAT3 dependent mechanism:implications for traumatic brain injury[J]. Journal of Neuroinflammation, 2017, 14(1): 65-82.

[25] [25] CAMPANA L, LEWIS P J S, PELLICORO A, et al. The STAT3-IL-10-IL-6 pathway is a novel regulator of macrophage efferocytosis and phenotypic conversion in sterile liver injury[J]. The Journal of Immunology, 2018, 200(3): 1169-1187.

[26] [26] KISSELEVA T, BHATTACHARYA S, BRAUNSTEIN J, et al. Signaling through the JAK/STAT pathway, recent advances and future challenges[J]. Gene, 2002, 285(1/2): 1-24.

[27] [27] RAWLINGS J S, ROSLER K M, HARRISON D A. The JAK/STAT signaling pathway[J]. Journal of Cell Science, 2004, 117(Pt 8): 1281-1283.

[28] [28] VILLARINO A V, KANNO Y, O’SHEA J J. Mechanisms and consequences of Jak-STAT signaling in the immune system[J]. Nature Immunology, 2017, 18(4): 374-384.

[29] [29] WEIS N, WEIGERT A, VON KNETHEN A, et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants[J]. Molecular Biology of the Cell, 2009, 20(5): 1280-1288.